Research and Markets: OTC Healthcare in Pakistan
* Reuters is not responsible for the content in this press release.
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/d0407c/otc_healthcare_in) has announced the addition of the "OTC Healthcare in Pakistan" report to their offering. The OTC Healthcare Products in Pakistan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2002-2007), allowing you to identify the sectors driving growth. Forecasts to 2012 illustrate how the market is set to change. Product coverage includes: cough, cold and allergy (hay fever) remedies, digestive remedies, medicated skin care, vitamins and dietary supplements, NRT smoking cessation aids, eye care, wound treatments, ear care, adult mouth care, calming and sleeping products. Data coverage: market sizes (historic and forecasts), company shares and brand shares. Why buy this report? * Get a detailed picture of the other hot drinks industry ; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market's major players and leading brands ; * Use five-year forecasts to assess how the market is predicted to develop Key Topics Covered: * OTC Healthcare in Pakistan * Euromonitor International : Country Market Insight * March 2009 * List of Contents and Tables * Executive Summary * Good Performance of OTC Healthcare * Urbanisation Fuelling OTC Sales * Multinational Companies Continue To Dominate Sales * Negligible Sales in Rural Areas * Demand Being Fuelled by Increasing Consumer Awareness and Literacy * Market Indicators * Table For more information visit http://www.researchandmarkets.com/research/d0407c/otc_healthcare_in Source: Euromonitor International Research and Markets Laura Wood Senior Manager Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 press@researchandmarkets.com Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters